Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin

NCT05575882 is registered in ClinicalTrials.gov with NAOS Argentina S.A. as lead sponsor.

NCT NCT05575882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05575882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin
Lead sponsor
NAOS Argentina S.A.
Phase
Not applicable
Overall status
Recruiting
Start date
November 3, 2022
Completion date
November 30, 2025
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema, atopic